Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Vilon

KE, L-Lys-L-Glu, lysylglutamic acid

Quick Stats
Studies 40
Trials 100
Score 1
2015 pubmed

Comparison of treatment options for experimental endometriosis in rats.

Aleksinskaya. E S ES; Nazarov. S B SB; Posiseeva. L V LV; Nazarova. A O AO; Malyshkina. A I AI

Key Findings

  • Surgery alone improved reproductive outcomes in rats with endometriosis.
  • Vilon alone had a modest effect on the condition.
  • The combination of surgery plus intraperitoneal Vilon was the most effective treatment in the animal model.

Practical Outcomes

  • The study suggests that Vilon might boost the benefits of surgery for endometriosis, but it was only tested in rats. There is no human dosage or safety data, so it isn’t ready for self‑experimentation or everyday use by biohackers.

Summary

In a rat study, researchers tested surgery, a drug called Vilon, and the two together for treating endometriosis. They found that combining surgery with an injection of Vilon into the abdomen gave the best results for the rats' reproductive health.

Abstract

The effectiveness of surgery, immunomodulator "Vilon" therapy, and their combination in the treatment of experimental endometriosis in rats was assessed by the parameters of reproductive function. The experiments demonstrated that surgery combined with intraperitoneal application of "Vilon" is a promising option in the treatment of endometriosis.

Study Information

Provider

pubmed

Year

2015

Date

2015-03-17T00:00:00.000Z

DOI

10.1007/s10517-015-2834-8

References

8